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INTRODUCTION
Shewanella algae rarely causes soft tissue and ear infections
in humans (1). The skin and soft tissue infections caused by
Shewanella spp. are commonly associated with chronic ulcers
or infected burns of the lower extremities (2, 3). Skin ulcers
have been reported to be colonized or infected with Shewanella
spp., and skin ulcers are the port of entry for systemic infec-
tions (4). Only one case of primary Shewanella septicemia with
skin and soft tissue manifestations (i.e., lower leg cellulitis)
occurring after raw seafood ingestion has been described (5). 
Because Korea is an endemic area for Vibrio vulnificus infec-
tions, primary septicemia with necrotizing fasciitis caused
by this organism has been well described in patients who give
a history of raw seafood ingestion and underlying hepatobil-
iary disease during the summer months (6). We report here-
in the first case of primary S. algae bacteremia with necrotiz-
ing fasciitis associated with raw seafood consumption which
mimicked V. vulnificus septicemia. 
CASE REPORT
A 58-yr-old man living in the southern area of Korea was
admitted to the Chonnam National University Hospital com-
plaining of painful swelling in both calves. The patient had
a history of alcoholic liver cirrhosis. Two days prior to admis-
sion, the patient had eaten raw fish. He had neither history
of trauma nor exposure to seawater. 
On admission, both lower legs were erythematous and ede-
matous, and hemorrhagic bullae were noted on the anterior
aspect of the left lower leg. The patient’s sclerae were icteric
and the abdomen was distended. The patient’s blood pressure
was 100/40 mmHg, the temperature was 36.5℃, the pulse
rate was 107 beats/min, and the respiration rate was 26/min.
Initial laboratory results were as follows: white blood cell
count, 4,200/μ L; hemoglobin, 8.8 g/μ L; platelet count, 55,000/
μ L; prothrombin time, 24.9 sec with an INR of 2.22; partial
thromboplastin time, 66.1 sec; total serum protein, 5.8 g/
dL; albumin, 2.5 g/dL; aspartate aminotransferase, 168 U/L;
alanine aminotransferase, 56 U/L; alkaline phosphatase, 56
U/L; total bilirubin, 14.9 mg/dL; blood urea nitrogen, 69.0
mg/dL; creatinine, 1.1 mg/dL; creatinine kinase, 750 U/L;
lactate dehydrogenase 767 U/L; erythrocyte sedimentation
rate, 43 mm/hr; and C-reactive protein, 17.4 mg/dL.
V. vulnificus septicemia was suspected based on the cutaneous
manifestation of necrotizing fasciitis, the history of liver cir-
rhosis, and raw seafood consumption. Blood and a bulla aspi-
rate were collected for bacteriologic cultures. The patient
received 2,000 mg/day of intravenous ceftriaxone and 800
mg/day of ciprofloxacin, and fasciotomies were performed
on the lower legs and dorsa of the feet. Despite treatment,
erythematous swelling spread to the thigh and a second fas-
ciotomy was performed on day 4 of hospitalization.
Cultures of blood, bulla aspirate, and tissue specimens ob-
tained from the patient’s calves yielded a gram-negative, non-
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Shewanella algae infections are rare in humans. Previously reported cases of S.
algae have mainly been associated with direct contact with seawater. We report a
case of primary S. algae bacteremia occurring after the ingestion of raw seafood in
a patient with liver cirrhosis that presented a fulminent course of necrotizing fasciitis.
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fermentative, oxidase-positive bacilli. The isolate showed
mucoid colony with β -hemolysis on blood agar plate after
48 hr incubation and H2S production on triple sugar iron
agar. It was identified as Shewanella putrefaciens by the auto-
matic identification systems using Vitek II (bioMerieux,
Marcy-L’Etoile, France) and API 20NE (bioMerieux) with a
probability of identification of 99.9%. Antimicrobial suscep-
tibility testing with AST-N055 card (bioMerieux) showed
susceptibility to all antibiotics except cefazolin. We performed
a nucleic acid-based confirmatory test by using 16S rRNA
gene sequencing analysis using the following primers: fD2
(5′ -AGAGTTTGATCATGGCTCAG-3′ ) and rP2 (5′ -ACG-
GCTACCTTGTTACGACTT-3′ ) (7). The isolate gene sequ-
ence showed 99% nucleotide similarities with the sequences
of S. algae strain ATCC 51192 (Gen Bank accession no. AB-
205581). Therefore, the clinical isolate was ultimately iden-
tified as S. algae. Additional antimicrobial susceptibility test
using disk diffusion method for the isolate showed suscepti-
bility to colistin. 
In spite of antibiotics and supportive care, bloody discharge
from the fasciotomy sites persisted. On day 10 of hospital-
ization, massive hematochezia developed. Endoscopy showed
esophageal and gastric varices with recent bleeding. On day
22 of hospitalization, the patient died with massive gastroin-
testinal bleeding and hepatic failure. 
DISCUSSION
Numerous pathogenic bacteria exist in seawater and in-
crease the risk of marine-acquired infections, including oti-
tis media, wound infections, gastroenteritis, and miscellaneous
tissue infections (8, 9). Such infections are usually associated
with direct exposure to seawater or ingestion of raw or under-
cooked seafood. Among the marine-acquired infections, the
epidemiology of S. algae infections is similar to infections in-
volving marine bacteria, such as Vibrio and Aeromonas. S. algae
can be isolated from seawater with water temperatures >13℃
during the summer season (10). Primary septicemia with
Vibrio and Aeromonas spp. mainly occur in patients who give
a history of raw seafood ingestion and underlying hepatobil-
iary diseases (11). In the case presented herein, a history of
raw seafood consumption in a patient with chronic liver dis-
ease and clinical manifestations of necrotizing fasciitis was
consistent with V. vulnificus septicemia.
The most commonly described Shewanella infections involve
the ears, skin, and soft tissues, with or without bacteremia
(1, 12). Three syndromes of bacteremia with Shewanella spp.
appear to exist as infections associated with the following
clinical conditions: 1) prematurity and congenital pneumo-
nia, 2) ulcerations of the lower extremities, and 3) an under-
lying disability, such as hepatobiliary disease or malignancy
(13). Other atypical clinical presentations include bone and
joint infections, meningitis, cerebellar abscesses, endocardi-
tis, infected aortic aneurysms, and ocular infections. To our
knowledge only 10 cases of Shewanella bacteremia in patients
with hepatobiliary diseases have been previously reported,
two in association with hepatobiliary infections, four in asso-
ciation with primary bacteremia without a recognizable source
of infection, three in association with skin and soft tissue infec-
tions, and one in association with pneumonia (5). In total, 5
of 10 patients died of sepsis, multiorgan failure, or both. All
10 cases were reported as S. putrefaciens without differentia-
tion from S. algae. Furthermore, as these organisms were iso-
lated together with other bacteria in 5 cases, the pathogenic
potential of Shewanella has been controversial. Among the
10 previously reported cases, only one patient with lower
leg cellulitis had a history of raw seafood ingestion without
any seawater exposure to the wound. This case of S. algae soft
tissue infection is unique, in that it appears to be the fist re-
ported instance of necrotizing fasciitis mimicking V. vulnifi-
cus septicemia, due to the ingestion of raw seafood in a patient
with hepatobiliary diseases and identified the species by 16S
rRNA gene sequencing analysis.
In the early 1990s, subgroup of Shewanella spp. was reclas-
sified as a new species, S. alga on the basis of genomic and
phenotypic studies (14, 15). When extensive phenotypic char-
acterization is performed, a large number of reports of human
infections allegedly reported by S. putrefaciens are caused by
S. algae (16, 17). Because the automated identification sys-
tems only include S. putrefaciens in their databases, but not
S. algae, they are unable to distinguish between S. putrefaciens
and S. algae. However, S. algae occupies >80% of isolates from
humans and is the more virulent species, as based on a murine
pathogenicity study performed by Khashe and Janda (18).
Therefore, optimal biochemical characterization to differen-
tiate between the two species is needed. Important differen-
tial characteristics between the two species include the abil-
ity of S. algae to produce mucoid colonies with β -hemolysis
on sheep blood agar, to grow at 42℃and in 6% NaCl, reduc-
tion of nitrite, and an inability to produce acid from maltose,
all of which are in contrast to the characteristics of S. putefa-
ciens. Additionally, S. algae is resistant to colistin, while S. pute-
faciens is susceptible. In this case, the isolate showed β -hemol-
ysis on sheep blood agar after incubation for 48 hr and did
not produce acid from maltose, findings consistent with S.
algae. However, the isolate was susceptible to colistin and did
not grow at 42℃ and in 6% NaCl, findings consistent with
S. putrefaciens. Therefore, we performed 16S rRNA gene se-
quencing analysis and identified the strain as S. algae.
The combination of a third-generation cephalosporin and
tetracycline or fluoroquinolone is recommended in antimi-
crobial treatment of V. vulnificus septicemic patients (7, 19),
whereas the combination of piperacillin with amikacin or
gentamicin in Shewanella infection (13). The combination of
ceftriaxone and ciprofloxacin was prescribed as empirical anti-
biotics for this patient because Vibrio septicemia was suspect-
ed based on clinical features. However, Shewanella spp. is usu-1194 D.S. Myung, Y.-S. Jung, S.-J. Kang, et al.
ally sensitive to commonly used antibiotics that target gram-
negative bacteria. Early recognition and aggressive surgical
intervention is also critical to decrease mortality in necrotiz-
ing fasciitis (20).
This case highlights the notion that S. algae infection should
be considered in the differential diagnosis of necrotizing fasci-
itis in patients with a history of raw seafood ingestion, espe-
cially in geographic areas endemic with V. vulnificus infections.
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